Connect with us

Technology

Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.

Published

on

Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery. 

WILMINGTON, Del., July 11, 2024 /PRNewswire/ — The global induced pluripotent stem cells industry was worth US$ 1.7 billion in 2023. By 2034, it is estimated to reach US$ 4.6 billion, expanding at a CAGR of 9.4% between 2024 and 2034. As reprogramming strategies improve, iPSCs become more feasible for many applications and more attractive to buyers.

The utilization of iPSCs in drug discovery and disease modeling is being accelerated by excessive-throughput screening technologies. Aside from heart disease, liver failure, and diabetes, iPSCs are capable of creating organ replacements. By doing so, the donor organ shortage can be addressed and the impact on affected people can be enhanced. Several wound recuperation treatments are possible with iPSCs, including those that treat excessive burns and chronic ulcers.

Cells from iPSCs can be used to develop new immunotherapies, such as CAR-T mobile treatments for cancer. Depending on the patient’s immune system, these treatment plans may enhance effectiveness and reduce side effects. Besides Parkinson’s disorder, spinal cord injuries, and macular degeneration, iPSCs can also be used to update damaged or diseased cells.

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30530

Induced Pluripotent Stem Cells Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 1.7 Bn

Forecast (Value) in 2034

US$ 4.6 Bn

Growth Rate (CAGR) 

9.4 %

No. of Pages 

156 Pages 

Segments covered 

By Cell Type, By Application, By End-user

Global Induced Pluripotent Stem Cells Market: Competitive Landscape

iPSC-based therapies can be commercialized more quickly with partnerships among educational institutions and biotech/pharmaceutical companies. By utilizing global studies networks and consortia, information can be shared, protocols are standardized, and problems can be collectively solved, propelling forward the iPSC industry.

 Key Players Profiled

Axol BioscienceCynata Therapeutics LimitedEvotec SEFate TherapeuticsFUJIFILM Cellular Dynamics Inc.NcardiaLizarBio TherapeuticsREPROCELL GlobalSumitomo Dainippon Pharma Company LimitedTakara Bio USA Inc.Thermo Fisher ScientificVertex Pharmaceuticals

Key Developments

In May 2023, Fujifilm Cellular Dynamics, a global provider of induced pluripotent stem cells (iPSC), and Novo Nordisk signed an agreement to jointly develop and commercialize iPSC-derived cell therapies targeting serious chronic conditions.In October 2023, Axol Bioscience and Sygnature Discovery were involved in a scientific collaboration to incorporate human induced pluripotent stem cells-derived microglia into vitroscreening workflows for high-content imaging.

Key Findings of the Market Report

As of 2023, diagnostic centers held the largest share of the market.In 2023, North America held the dominant position in the market.In terms of cell type, fibroblasts are likely to be the primary driver of induced pluripotent stem cell demand.The use of stem cells for regenerative medicine is expected to increase in the near future.A growing number of pharmaceutical and biotechnology companies are expected to expand their offerings. 

Global Induced Pluripotent Stem Cells Market: Growth Drivers

The development of gene-enhancing technologies, including CRISPR-Cas9, has improved the production and precision of iPSCs significantly. By using these technologies, genetic defects can be corrected, and illness fashions can be introduced.In recent years, technology has improved the ease and safety of converting somatic cells into iPSCs, allowing them to be used in medical procedures. Manufacturing and analyzing iPSCs have been streamlined by automation and high-throughput screening technology, enabling big-scale research and cutting costs.The iPSCs are crucial to growing regenerative therapies for damaged tissues and organs. A capacity solution has been developed for coronary heart disease, spinal cord injuries, and neurodegenerative diseases. In oncology and chronic illness management, iPSCs can be derived from a patient’s own cells to minimize the chance of immune rejection.Using iPSCs, researchers can build disease-specific mobile models, allowing them to study disease mechanisms and screen potential drugs more effectively. Using iPSCs reduces the reliance on animal models and improves the predictability of human responses to toxicology.

 Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30530 

Global Induced Pluripotent Stem Cells Market: Regional Landscape

North America has numerous international-renowned research institutions and universities that are at the leading edge of stem cell studies. IPSCs are used in basic studies, drug discovery, and disease modeling by these establishments. The National Institutes of Health (NIH) together with government groups provide significant funding for research on iPSCs.iPSCs have been the subject of an excessive number of clinical trials throughout North America, indicating their ability to grow new therapies. Several successful trials and future cures are expected to increase demand. A stem cell bank or repository in the status quo facilitates the use of iPSCs for therapeutic and research purposes.The iPSC is a viable alternative to embryonic stem cells that bypasses many of the ethical issues associated with embryonic stem cells. Increasing public awareness about stem cell research and its benefits increases support for iPSC-based improvements.

Global Induced Pluripotent Stem Cells Market: Segmentation

Cell Type

HepatocytesFibroblastsKeratinocytesOthers (Neurons, etc.)

Application

Drug DevelopmentRegenerative MedicineToxicity TestingTissue EngineeringCell TherapyDisease Modeling

End User

HospitalsDiagnostic CentersPharmaceutical & Biotechnology CompaniesContract Research OrganizationsOthers (Academic & Research Institutes, etc.)

Region

North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=30530&ltype=S 

More Trending Report by Transparency Market Research:

Geriatric Care Services Market to Grow at a 7.3% CAGR from 2023 to 2028, reaching US$ 0.7 billion: TMR ReportPreeclampsia Diagnostics Market Set to Reach USD 2.3 Billion by 2031, growing at a CAGR of 3.8%: TMR ReportMedical Case Management Market is expected to grow at a CAGR of 6.1% from 2024 to 2034 and reach US$ 12.3 Bn by the end of 2034.Lucid Dreaming Devices Market is expected to grow at a CAGR of 5.1% from 2024 to 2034 and reach US$ 196.8 Mn by the end of 2034.

About Transparency Market Research 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com  
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn Twitter Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/induced-pluripotent-stem-cells-market-size-is-expected-to-grow-at-a-cagr-of-9-4-and-reach-usd-4-6-billion-by-2034-transparency-market-research-inc-302194822.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Eficode receives Atlassian Partner of the Year 2026 for Software Solutions

Published

on

By

Eficode has been named Atlassian Partner of the Year 2026 for Software Solutions, recognizing performance in new business development, thought leadership, and delivering solutions that complement Atlassian’s offering.

HELSINKI, May 5, 2026 /PRNewswire/ — Atlassian announced today that Eficode has been awarded the Atlassian Partner of the Year 2026 for Software Solutions in recognition of their exemplary contributions and achievements throughout the calendar year 2025. This accolade acknowledges exceptional performance in new business development, thought leadership, and the delivery of products and services that effectively complement Atlassian’s offerings.

Eficode was among the select group of partners honored at the annual Atlassian Partner of the Year awards, in recognition of their sustained commitment and outstanding customer engagement.

“Our Partner of the Year winners represent the very best of our ecosystem—driving innovation, delivering cutting-edge solutions, and demonstrating an unwavering commitment to customer success. We are proud to celebrate their achievements and recognize the incredible impact they’ve made in helping customers unlock their full potential with Atlassian,” said Bill Hustad, Head of Channel and GTM Ecosystems at Atlassian.

“This recognition reflects the trust our customers place in us and the dedication of our teams every day. We focus on helping organizations use AI in the software development lifecycle and build effective software tooling that supports real business outcomes. It’s rewarding to see the impact this has on our clients’ success, and we’re excited to keep building on that with Atlassian,” said Henri Hämäläinen, Chief Product Officer and Co-CEO of Eficode.

Eficode brings deep experience in AI-driven software development and building effective SDLC tooling that helps teams work smarter. They have supported organizations such as Air France–KLM, Supercell, and The Very Group in saving costs, future-proofing their environment for innovation, and building more efficient software processes and better customer experiences. Learn more about Eficode’s work with Atlassian solutions.

Media contacts
Henri Hämäläinen, CPO, Co-CEO at Eficode, henri.hamalainen@eficode.com, +358 50 487 3291
Simon Wood, CRO, Co-CEO at Eficode, simon.wood@eficode.com, +44 7920 002769

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/eficode-oy/r/eficode-receives-atlassian-partner-of-the-year-2026-for-software-solutions,c4343859

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/eficode-receives-atlassian-partner-of-the-year-2026-for-software-solutions-302762305.html

Continue Reading

Technology

Bizcap launches Line of Credit in Europe to meet growing SME demand

Published

on

By

MUNICH, May 5, 2026 /PRNewswire/ — Small and medium-sized enterprises (SMEs) in Europe can now access up to €500,000 in funding thanks to a flexible, fast-turnaround line of credit offered by Bizcap.

The Line of Credit is designed to help businesses manage cash flow, respond to seasonal pressures, and act on growth opportunities. The new facility offers set-up within two to three days, followed by ongoing access to funds as needed.

Bizcap’s Business Line of Credit gives SMEs a more adaptable funding solution than many traditional lending products, with flexible drawdowns and repayments aligned to business cash flow. Businesses only pay for the funds they use, and once the facility is in place, they can access capital as needed without having to reapply each time.

The launch comes as Bizcap builds on a strong start in Europe, following its launch into Luxembourg in July 2025, then expanding lending into Germany in October 2025, where it facilitated more than €4 million in funding in its first month of lending. Bizcap has described Germany as its most successful international expansion to date, underlining strong product-market fit and the effectiveness of its partnerships-led strategy in Europe.

“Europe has responded favourably to Bizcap’s fast, flexible and transparent approach to funding, and that’s exactly why this Line of Credit launch matters,” said Laura Schlag, Managing Partner for Bizcap Europe.

“Our early traction in Luxembourg and Germany showed us there is clear demand from SMEs for funding that moves at the speed of business. With our Line of Credit, businesses can access capital when they need it, use only what they need, and stay in control of their cash flow.

“For many SMEs, funding needs don’t arrive in one neat moment. They ebb and flow with stock purchases, supplier payments, payroll, tax obligations, and growth opportunities. This product is designed to meet that reality with flexibility, speed and clarity.”

Bizcap’s Line of Credit has already proven itself in other international markets, where the product has seen strong uptake from SMEs seeking reliable working capital and repeat access to funding. Its expansion into Europe reflects Bizcap’s broader strategy to bring practical, flexible business finance to underserved SME markets.

Albert Gahfi, Bizcap’s Global Co-CEO, said the launch of Line of Credit in Europe reflects both market demand and Bizcap’s confidence in the region’s long-term potential.

“We’ve seen in Luxembourg and Germany just how strongly SMEs and partners respond when funding is fast, transparent and built around real business needs,” he said.

“Launching our Line of Credit in Europe is a natural next step. It gives businesses an ongoing source of capital they can draw on as opportunities arise, without the friction of starting from scratch each time.

“Our model is built to move quickly, but it’s also built to understand businesses properly. We look beyond rigid scorecards and assess overall financial health, which means we can support a broader range of SMEs with practical, responsible funding solutions.”

This broader underwriting approach and Bizcap’s focus on overall business health are themes the company has highlighted in its European rollout.

Bizcap works closely with advisers, brokers and partners across its markets to help deliver funding solutions to a broader range of business clients. In Europe, that partnership-led approach has already played a major role in its early growth, where Bizcap says trust, credibility and strong broker relationships were key to its first-month results.

Bizcap is offering select advisers access to bring this solution to their clients. Interested advisers can email partners@bizcap.eu or become a partner via their website.

View original content:https://www.prnewswire.co.uk/news-releases/bizcap-launches-line-of-credit-in-europe-to-meet-growing-sme-demand-302762228.html

Continue Reading

Technology

Frost & Sullivan Recognizes Picus Security as the 2026 Global Company of the Year for Advancing Automated Security Validation

Published

on

By

Recognition highlights Picus for pioneering a unified, AI-driven approach that is reshaping the security validation market and delivering meaningful customer impact

SAN ANTONIO, May 5, 2026 /PRNewswire/ — Frost & Sullivan today announced that it has awarded Picus Security the 2026 Global Company of the Year recognition in the automated security validation industry. This recognition highlights Picus Security’s consistent leadership in delivering measurable security outcomes, advancing innovation, and driving customer impact in a rapidly evolving threat landscape.

Each year, Frost & Sullivan presents the Company of the Year recognition to an organization that demonstrates outstanding strategy development and implementation. The firm evaluates companies based on a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Picus Security excelled in both, aligning its long-term vision with enterprise security needs while executing efficiently at scale. The company’s strategic agility and sustained investment in autonomous exposure validation have enabled it to scale effectively across North America, Asia-Pacific, and other global markets, serving large enterprises across sectors such as BFSI, healthcare, government, and technology.

“Picus Security’s rapid growth, diversified revenue streams, expanding global presence, and strong partner ecosystem reflect a company entering a new phase of accelerated scale. Its platform breadth, enterprise adoption, and continued investments across integrations, alliances, marketplaces, and service providers position it to play a pivotal role in advancing the automated security validation market,” said Ying Ting Neoh, an industry analyst at Frost & Sullivan.

Picus Security continues to differentiate through a unified, AI-driven security validation platform that integrates breach and attack simulation, automated pentesting, and autonomous exposure validation to measure real exploitability, correlate siloed findings, and reveal the small fraction of exposures that truly matter. With evidence-based reporting, compensating control guidance, and always-up-to-date attack content, Picus Security transforms enterprise security validation into a continuous, automated, and intelligence-driven practice.

“We’ve entered the Post-Mythos and GPT-Cyber era. Frontier AI models can now write exploits and launch autonomous attacks against thousands of targets in parallel, yet most enterprises are still validating their defenses at human speed,” said Volkan Ertürk, co-founder and CTO of Picus Security. “That gap is no longer survivable with periodic pentesting or manual red teaming. It demands autonomous validation: continuous, AI-driven proof that your controls hold and your real exploitable paths are closed. Frost & Sullivan’s recognition affirms that Picus is leading this shift, and that the market is ready for it.”

Frost & Sullivan commends Picus Security for setting a high standard in competitive strategy, execution, and market responsiveness. The company’s vision, innovation pipeline, and customer-first approach are shaping the future of the automated security validation industry and enabling enterprises to manage cyber risk in dynamic environments proactively.

Learn more about Picus Security’s innovation at https://www.picussecurity.com/resource/blog/why-frost-sullivan-named-picus-2026-global-company-of-the-year

Frost & Sullivan Best Practices Recognition
Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.

Contact us: Start the discussion.

About Picus Security
Picus Security, the leading security validation company, gives organizations a clear picture of their cyber risk based on business context. Picus transforms security practices by correlating, prioritizing and validating exposures across siloed findings so teams can focus on critical gaps and high-impact fixes. With Picus, security teams can quickly take action with one-click mitigations to stop more threats with less effort. Offering Adversarial Exposure Validation with Breach and Attack Simulation and Automated Penetration Testing, working together for greater outcomes, Picus delivers award-winning, threat-centric technology that allows teams to pinpoint fixes worth pursuing.

Follow Picus Security on X and LinkedIn.

Frost & Sullivan Media Contact:
Tarini Singh
E: Tarini.Singh@frost.com

Media Contact
Jennifer Tanner
Look Left Marketing
picus@lookleftmarketing.com

View original content:https://www.prnewswire.com/news-releases/frost–sullivan-recognizes-picus-security-as-the-2026-global-company-of-the-year-for-advancing-automated-security-validation-302761249.html

SOURCE Frost & Sullivan

Continue Reading

Trending